Emerging Roles of Nanocarrier in Cancer Therapy - Singh, Arun Kumar; Malviya, Rishabha; Sundram, Sonali
139,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

The book emphasizes the application of nanocarrier systems in the field of cancer therapy. It covers recent strategies for siRNA delivery based on smart nanocarriers by using stimuli-responsive materials. The text highlights the roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The book emphasizes the application of nanocarrier systems in the field of cancer therapy. It covers recent strategies for siRNA delivery based on smart nanocarriers by using stimuli-responsive materials. The text highlights the roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy.
Autorenporträt
Dr Rishabha Malviya completed B. Pharmacy from Uttar Pradesh Technical University and M. Pharmacy (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His PhD (Pharmacy) work was in the area of Novel formulation development techniques. He has more than 12.5 years of research experience and presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University since past 8 years. His area of interest includes formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients. Arun Kumar Singh completed his B Pharm and M Pharm from Galgotias University India. Prof Sonali Sundram completed B. Pharm & M. Pharm (Pharmacology) from AKTU, Lucknow. She has worked as research scientist in project of ICMR in King George's Medical University, Lucknow after that she has joined BBDNIIT and currently she is working in Galgotias University, Greater Noida, India. Her PhD (Pharmacy) work was in the area of Neurodegeneration and Nanoformulation. Her area of interest is neurodegeneration, clinical research, artificial intelligence.